img

Global Neurosurgery Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neurosurgery Drug Market Insights, Forecast to 2034

Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
Global Neurosurgery Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Neurosurgery Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Neurosurgery Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Neurosurgery Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals
Segment by Type
Tablets
Solution
Capsules
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Neurosurgery Drug plant distribution, commercial date of Neurosurgery Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Neurosurgery Drug introduction, etc. Neurosurgery Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Neurosurgery Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Neurosurgery Drug Product Introduction
1.2 Market by Type
1.2.1 Global Neurosurgery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Solution
1.2.4 Capsules
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurosurgery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neurosurgery Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Neurosurgery Drug Revenue by Region
2.2.1 Global Neurosurgery Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Neurosurgery Drug Revenue by Region (2018-2024)
2.2.3 Global Neurosurgery Drug Revenue by Region (2024-2029)
2.2.4 Global Neurosurgery Drug Revenue Market Share by Region (2018-2029)
2.3 Global Neurosurgery Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Neurosurgery Drug Sales by Region
2.4.1 Global Neurosurgery Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Neurosurgery Drug Sales by Region (2018-2024)
2.4.3 Global Neurosurgery Drug Sales by Region (2024-2029)
2.4.4 Global Neurosurgery Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Neurosurgery Drug Sales by Manufacturers
3.1.1 Global Neurosurgery Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Neurosurgery Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurosurgery Drug in 2022
3.2 Global Neurosurgery Drug Revenue by Manufacturers
3.2.1 Global Neurosurgery Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Neurosurgery Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Neurosurgery Drug Revenue in 2022
3.3 Global Key Players of Neurosurgery Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Neurosurgery Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Neurosurgery Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Neurosurgery Drug, Product Offered and Application
3.8 Global Key Manufacturers of Neurosurgery Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurosurgery Drug Sales by Type
4.1.1 Global Neurosurgery Drug Historical Sales by Type (2018-2024)
4.1.2 Global Neurosurgery Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Neurosurgery Drug Sales Market Share by Type (2018-2029)
4.2 Global Neurosurgery Drug Revenue by Type
4.2.1 Global Neurosurgery Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Neurosurgery Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Neurosurgery Drug Revenue Market Share by Type (2018-2029)
4.3 Global Neurosurgery Drug Price by Type
4.3.1 Global Neurosurgery Drug Price by Type (2018-2024)
4.3.2 Global Neurosurgery Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Neurosurgery Drug Sales by Application
5.1.1 Global Neurosurgery Drug Historical Sales by Application (2018-2024)
5.1.2 Global Neurosurgery Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Neurosurgery Drug Sales Market Share by Application (2018-2029)
5.2 Global Neurosurgery Drug Revenue by Application
5.2.1 Global Neurosurgery Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Neurosurgery Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Neurosurgery Drug Revenue Market Share by Application (2018-2029)
5.3 Global Neurosurgery Drug Price by Application
5.3.1 Global Neurosurgery Drug Price by Application (2018-2024)
5.3.2 Global Neurosurgery Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Neurosurgery Drug Market Size by Type
6.1.1 US & Canada Neurosurgery Drug Sales by Type (2018-2029)
6.1.2 US & Canada Neurosurgery Drug Revenue by Type (2018-2029)
6.2 US & Canada Neurosurgery Drug Market Size by Application
6.2.1 US & Canada Neurosurgery Drug Sales by Application (2018-2029)
6.2.2 US & Canada Neurosurgery Drug Revenue by Application (2018-2029)
6.3 US & Canada Neurosurgery Drug Market Size by Country
6.3.1 US & Canada Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Neurosurgery Drug Sales by Country (2018-2029)
6.3.3 US & Canada Neurosurgery Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Neurosurgery Drug Market Size by Type
7.1.1 Europe Neurosurgery Drug Sales by Type (2018-2029)
7.1.2 Europe Neurosurgery Drug Revenue by Type (2018-2029)
7.2 Europe Neurosurgery Drug Market Size by Application
7.2.1 Europe Neurosurgery Drug Sales by Application (2018-2029)
7.2.2 Europe Neurosurgery Drug Revenue by Application (2018-2029)
7.3 Europe Neurosurgery Drug Market Size by Country
7.3.1 Europe Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Neurosurgery Drug Sales by Country (2018-2029)
7.3.3 Europe Neurosurgery Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Neurosurgery Drug Market Size
8.1.1 China Neurosurgery Drug Sales (2018-2029)
8.1.2 China Neurosurgery Drug Revenue (2018-2029)
8.2 China Neurosurgery Drug Market Size by Application
8.2.1 China Neurosurgery Drug Sales by Application (2018-2029)
8.2.2 China Neurosurgery Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neurosurgery Drug Market Size by Type
9.1.1 Asia Neurosurgery Drug Sales by Type (2018-2029)
9.1.2 Asia Neurosurgery Drug Revenue by Type (2018-2029)
9.2 Asia Neurosurgery Drug Market Size by Application
9.2.1 Asia Neurosurgery Drug Sales by Application (2018-2029)
9.2.2 Asia Neurosurgery Drug Revenue by Application (2018-2029)
9.3 Asia Neurosurgery Drug Sales by Region
9.3.1 Asia Neurosurgery Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Neurosurgery Drug Revenue by Region (2018-2029)
9.3.3 Asia Neurosurgery Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Neurosurgery Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Neurosurgery Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Neurosurgery Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Neurosurgery Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Neurosurgery Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Neurosurgery Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Neurosurgery Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Neurosurgery Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Neurosurgery Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Neurosurgery Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Overview
11.3.3 Biogen Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Biogen Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Recent Developments
11.4 Jhonson & Jhonson
11.4.1 Jhonson & Jhonson Company Information
11.4.2 Jhonson & Jhonson Overview
11.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Jhonson & Jhonson Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jhonson & Jhonson Recent Developments
11.5 ABBVIE
11.5.1 ABBVIE Company Information
11.5.2 ABBVIE Overview
11.5.3 ABBVIE Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 ABBVIE Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ABBVIE Recent Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Company Information
11.6.2 Takeda Pharmaceuticals Overview
11.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Pharmaceuticals Recent Developments
11.7 UCB
11.7.1 UCB Company Information
11.7.2 UCB Overview
11.7.3 UCB Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 UCB Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UCB Recent Developments
11.8 IPSEN
11.8.1 IPSEN Company Information
11.8.2 IPSEN Overview
11.8.3 IPSEN Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 IPSEN Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IPSEN Recent Developments
11.9 Standigm
11.9.1 Standigm Company Information
11.9.2 Standigm Overview
11.9.3 Standigm Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Standigm Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Standigm Recent Developments
11.10 BlueStar Genomic
11.10.1 BlueStar Genomic Company Information
11.10.2 BlueStar Genomic Overview
11.10.3 BlueStar Genomic Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 BlueStar Genomic Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BlueStar Genomic Recent Developments
11.11 Tonix Pharmaceuticals
11.11.1 Tonix Pharmaceuticals Company Information
11.11.2 Tonix Pharmaceuticals Overview
11.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tonix Pharmaceuticals Recent Developments
11.12 BlackThorn Therapeutics
11.12.1 BlackThorn Therapeutics Company Information
11.12.2 BlackThorn Therapeutics Overview
11.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BlackThorn Therapeutics Recent Developments
11.13 Quentrix
11.13.1 Quentrix Company Information
11.13.2 Quentrix Overview
11.13.3 Quentrix Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Quentrix Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Quentrix Recent Developments
11.14 Wren Pharmaceuticals
11.14.1 Wren Pharmaceuticals Company Information
11.14.2 Wren Pharmaceuticals Overview
11.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Wren Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurosurgery Drug Industry Chain Analysis
12.2 Neurosurgery Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurosurgery Drug Production Mode & Process
12.4 Neurosurgery Drug Sales and Marketing
12.4.1 Neurosurgery Drug Sales Channels
12.4.2 Neurosurgery Drug Distributors
12.5 Neurosurgery Drug Customers
13 Market Dynamics
13.1 Neurosurgery Drug Industry Trends
13.2 Neurosurgery Drug Market Drivers
13.3 Neurosurgery Drug Market Challenges
13.4 Neurosurgery Drug Market Restraints
14 Key Findings in The Global Neurosurgery Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurosurgery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Solution
Table 4. Major Manufacturers of Capsules
Table 5. Major Manufacturers of Others
Table 6. Global Neurosurgery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Neurosurgery Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Neurosurgery Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Neurosurgery Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Neurosurgery Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Neurosurgery Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Neurosurgery Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 15. Global Neurosurgery Drug Sales Market Share by Region (2018-2024)
Table 16. Global Neurosurgery Drug Sales Market Share by Region (2024-2029)
Table 17. Global Neurosurgery Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Neurosurgery Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Neurosurgery Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Neurosurgery Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Neurosurgery Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Neurosurgery Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Neurosurgery Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Neurosurgery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2022)
Table 25. Global Key Manufacturers of Neurosurgery Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Neurosurgery Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Neurosurgery Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 30. Global Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 31. Global Neurosurgery Drug Sales Share by Type (2018-2024)
Table 32. Global Neurosurgery Drug Sales Share by Type (2024-2029)
Table 33. Global Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Neurosurgery Drug Revenue Share by Type (2018-2024)
Table 36. Global Neurosurgery Drug Revenue Share by Type (2024-2029)
Table 37. Neurosurgery Drug Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Neurosurgery Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 40. Global Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 41. Global Neurosurgery Drug Sales Share by Application (2018-2024)
Table 42. Global Neurosurgery Drug Sales Share by Application (2024-2029)
Table 43. Global Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Neurosurgery Drug Revenue Share by Application (2018-2024)
Table 46. Global Neurosurgery Drug Revenue Share by Application (2024-2029)
Table 47. Neurosurgery Drug Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Neurosurgery Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Neurosurgery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 62. Europe Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 63. Europe Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 64. Europe Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 67. Europe Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 68. Europe Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Neurosurgery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 74. Europe Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 75. China Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 76. China Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 77. China Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 80. China Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 81. China Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 84. Asia Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 85. Asia Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 88. Asia Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 89. Asia Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Neurosurgery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Neurosurgery Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Neurosurgery Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 95. Asia Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Neurosurgery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Neurosurgery Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 109. Pfizer Company Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Pfizer Recent Developments
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Description and Major Businesses
Table 116. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AstraZeneca Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AstraZeneca Recent Developments
Table 119. Biogen Company Information
Table 120. Biogen Description and Major Businesses
Table 121. Biogen Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Biogen Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Biogen Recent Developments
Table 124. Jhonson & Jhonson Company Information
Table 125. Jhonson & Jhonson Description and Major Businesses
Table 126. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Jhonson & Jhonson Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Jhonson & Jhonson Recent Developments
Table 129. ABBVIE Company Information
Table 130. ABBVIE Description and Major Businesses
Table 131. ABBVIE Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. ABBVIE Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. ABBVIE Recent Developments
Table 134. Takeda Pharmaceuticals Company Information
Table 135. Takeda Pharmaceuticals Description and Major Businesses
Table 136. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Takeda Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Takeda Pharmaceuticals Recent Developments
Table 139. UCB Company Information
Table 140. UCB Description and Major Businesses
Table 141. UCB Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. UCB Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. UCB Recent Developments
Table 144. IPSEN Company Information
Table 145. IPSEN Description and Major Businesses
Table 146. IPSEN Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. IPSEN Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. IPSEN Recent Developments
Table 149. Standigm Company Information
Table 150. Standigm Description and Major Businesses
Table 151. Standigm Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Standigm Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Standigm Recent Developments
Table 154. BlueStar Genomic Company Information
Table 155. BlueStar Genomic Description and Major Businesses
Table 156. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. BlueStar Genomic Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. BlueStar Genomic Recent Developments
Table 159. Tonix Pharmaceuticals Company Information
Table 160. Tonix Pharmaceuticals Description and Major Businesses
Table 161. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Tonix Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Tonix Pharmaceuticals Recent Developments
Table 164. BlackThorn Therapeutics Company Information
Table 165. BlackThorn Therapeutics Description and Major Businesses
Table 166. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. BlackThorn Therapeutics Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. BlackThorn Therapeutics Recent Developments
Table 169. Quentrix Company Information
Table 170. Quentrix Description and Major Businesses
Table 171. Quentrix Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Quentrix Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Quentrix Recent Developments
Table 174. Wren Pharmaceuticals Company Information
Table 175. Wren Pharmaceuticals Description and Major Businesses
Table 176. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Wren Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Wren Pharmaceuticals Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Neurosurgery Drug Distributors List
Table 182. Neurosurgery Drug Customers List
Table 183. Neurosurgery Drug Market Trends
Table 184. Neurosurgery Drug Market Drivers
Table 185. Neurosurgery Drug Market Challenges
Table 186. Neurosurgery Drug Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurosurgery Drug Product Picture
Figure 2. Global Neurosurgery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Neurosurgery Drug Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Solution Product Picture
Figure 6. Capsules Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurosurgery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Neurosurgery Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Neurosurgery Drug Report Years Considered
Figure 14. Global Neurosurgery Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Neurosurgery Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global Neurosurgery Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Neurosurgery Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global Neurosurgery Drug Sales 2018-2029 ((K Units)
Figure 19. Global Neurosurgery Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Neurosurgery Drug Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Neurosurgery Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Neurosurgery Drug Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Neurosurgery Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Neurosurgery Drug Sales YoY (2018-2029) & (K Units)
Figure 25. China Neurosurgery Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Neurosurgery Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Neurosurgery Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Neurosurgery Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Neurosurgery Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Neurosurgery Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Neurosurgery Drug in the World: Market Share by Neurosurgery Drug Revenue in 2022
Figure 32. Global Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 34. Global Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 36. Global Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Neurosurgery Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada Neurosurgery Drug Sales Share by Country (2018-2029)
Figure 43. U.S. Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe Neurosurgery Drug Revenue Share by Country (2018-2029)
Figure 50. Europe Neurosurgery Drug Sales Share by Country (2018-2029)
Figure 51. Germany Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 57. China Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 58. China Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 59. China Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia Neurosurgery Drug Revenue Share by Region (2018-2029)
Figure 65. Asia Neurosurgery Drug Sales Share by Region (2018-2029)
Figure 66. Japan Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Neurosurgery Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Neurosurgery Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Neurosurgery Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Neurosurgery Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Neurosurgery Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Neurosurgery Drug Sales Share by Country (2018-2029)
Figure 77. Brazil Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Neurosurgery Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Neurosurgery Drug Value Chain
Figure 83. Neurosurgery Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries